Overview

Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The primary study objective is to demonstrate the efficacy of dianicline as an aid to smoking cessation in cigarette smokers. The main secondary objectives are to assess the: craving for cigarettes, nicotine withdrawal symptoms, and safety of dianicline.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi